Hypera S.A. (HYPMY)
OTCMKTS · Delayed Price · Currency is USD
4.690
-0.170 (-3.50%)
At close: Dec 5, 2025
Hypera Market Cap
Hypera has a market cap or net worth of $2.96 billion as of December 5, 2025. Its market cap has increased by 31.80% in one year.
Market Cap
2.96B
Enterprise Value
4.35B
Revenue
1.31B
Ranking
n/a
PE Ratio
19.17
Stock Price
$4.69
Market Cap Chart
Since April 18, 2008, Hypera's market cap has increased from 1.59B to 2.96B, an increase of 86.73%. That is a compound annual growth rate of 3.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.96B | 61.44% |
| Dec 30, 2024 | 1.84B | -60.72% |
| Dec 28, 2023 | 4.67B | -14.36% |
| Dec 29, 2022 | 5.46B | 70.31% |
| Dec 30, 2021 | 3.20B | -23.62% |
| Dec 30, 2020 | 4.20B | -25.09% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 558.58M |
| Glass House Brands | 531.36M |
| CytoDyn | 403.93M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 336.78M |
| Nika Pharmaceuticals | 259.91M |